Pharma Mar (OTCMKTS:PHMMF) Hits New 12-Month High – Time to Buy?

Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF) reached a new 52-week high during trading on Wednesday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares changing hands. The stock had previously closed at $75.00.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital raised shares of Pharma Mar to a “strong-buy” rating in a report on Thursday, August 1st.

Pharma Mar Stock Performance

The business has a 50-day simple moving average of $57.03 and a 200-day simple moving average of $40.93. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.